1. Home
  2. RNXT vs GLBS Comparison

RNXT vs GLBS Comparison

Compare RNXT & GLBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • GLBS
  • Stock Information
  • Founded
  • RNXT 2012
  • GLBS 2006
  • Country
  • RNXT United States
  • GLBS Greece
  • Employees
  • RNXT N/A
  • GLBS N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • GLBS Marine Transportation
  • Sector
  • RNXT Health Care
  • GLBS Consumer Discretionary
  • Exchange
  • RNXT Nasdaq
  • GLBS Nasdaq
  • Market Cap
  • RNXT 30.0M
  • GLBS 25.9M
  • IPO Year
  • RNXT 2021
  • GLBS 2007
  • Fundamental
  • Price
  • RNXT $1.27
  • GLBS $1.07
  • Analyst Decision
  • RNXT Strong Buy
  • GLBS
  • Analyst Count
  • RNXT 2
  • GLBS 0
  • Target Price
  • RNXT $6.50
  • GLBS N/A
  • AVG Volume (30 Days)
  • RNXT 118.6K
  • GLBS 58.0K
  • Earning Date
  • RNXT 11-13-2024
  • GLBS 11-29-2024
  • Dividend Yield
  • RNXT N/A
  • GLBS N/A
  • EPS Growth
  • RNXT N/A
  • GLBS 61.29
  • EPS
  • RNXT N/A
  • GLBS 0.14
  • Revenue
  • RNXT N/A
  • GLBS $33,289,000.00
  • Revenue This Year
  • RNXT N/A
  • GLBS $15.39
  • Revenue Next Year
  • RNXT N/A
  • GLBS $43.34
  • P/E Ratio
  • RNXT N/A
  • GLBS $8.14
  • Revenue Growth
  • RNXT N/A
  • GLBS 2.74
  • 52 Week Low
  • RNXT $0.68
  • GLBS $1.06
  • 52 Week High
  • RNXT $2.35
  • GLBS $3.15
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 52.77
  • GLBS 28.49
  • Support Level
  • RNXT $1.21
  • GLBS $1.10
  • Resistance Level
  • RNXT $1.55
  • GLBS $1.39
  • Average True Range (ATR)
  • RNXT 0.12
  • GLBS 0.10
  • MACD
  • RNXT -0.02
  • GLBS -0.02
  • Stochastic Oscillator
  • RNXT 32.20
  • GLBS 5.74

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About GLBS Globus Maritime Limited

Globus Maritime Ltd is a dry bulk shipping company that provides marine transportation services internationally. The company owns, operates, and manages a fleet of dry bulk vessels that transport iron ore, coal, grain, steel products, cement, alumina, and other dry bulk cargo. Its operations are managed by its subsidiary which also provides in-house commercial and technical management for its vessels and also offers consulting services for an affiliated ship management company. It generates maximum revenues by charging customers for the use of vessels to transport dry bulk commodities.

Share on Social Networks: